4.4 Article

Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers

Journal

INFECTION AND IMMUNITY
Volume 90, Issue 4, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/iai.00389-21

Keywords

typhoid fever; single nucleotide polymorphism; transcriptome; Salmonella Typhi; genomics; unfolded protein response; HLA antigens

Funding

  1. Wellcome Trust [092661/Z/10/Z, 090532/Z/09/Z]
  2. Bill & Melinda Gates Foundation [OPP1084259, OPP1113682]
  3. European Commission FP7 grant Advanced Immunization Technologies (ADITEC)
  4. NIHR Oxford Biomedical Research Centre
  5. Wellcome Trust [092661/Z/10/Z] Funding Source: Wellcome Trust
  6. Bill and Melinda Gates Foundation [OPP1084259] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

This study utilized controlled challenge experiments to identify genetic variants associated with susceptibility to enteric fever. The findings suggest that specific HLA types and gene expression patterns may influence susceptibility to enteric fever.
Infections with Salmonella enterica serovars Typhi and Paratyphi A cause an estimated 14 million cases of enteric fever annually. Here, the controlled nature of challenge studies is exploited to identify genetic variants associated with enteric fever susceptibility. Human challenge participants were genotyped by Illumina OmniExpress-24 BeadChip array (n = 176) and/or transcriptionally profiled by RNA sequencing (n = 174). While the study was underpowered to detect any single nucleotide polymorphisms (SNPs) significant at the whole-genome level, two SNPs within CAPN14 and MIATNB were identified with P < 10(-5) for association with development of symptoms or bacteremia following oral S. Typhi or S. Paratyphi A challenge. Imputation of classical human leukocyte antigen (HLA) types from genomic and transcriptomic data identified HLA-B*27:05, previously associated with nontyphoidal Salmonella-induced reactive arthritis, as the HLA type most strongly associated with enteric fever susceptibility (P = 0.011). Gene sets relating to the unfolded protein response/heat shock and endoplasmic reticulum-associated protein degradation were overrepresented in HLA-B*27:05(+) participants following challenge. Furthermore, intracellular replication of S. Typhi is higher in C1R cells transfected with HLA-B*27:05 (P = 0.02). These data suggest that activation of the unfolded protein response by HLA-B*27:05 misfolding may create an intracellular environment conducive to S. Typhi replication, increasing susceptibility to enteric fever.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

HLA-A,-B,-C,-DPB1,-DQB1 and-DRB1 allele frequencies of North Tanzanian Maasai

Amber Barton, Athumani Ramadhani, Elias Mafuru, Tara Mtuy, Patrick Massae, Aiweda Malissa, Tamsyn Derrick, Joanna Houghton, Anna Harte, Thomas Payne, Harry Pickering, Matthew J. Burton, Chrissy H. Roberts, Martin J. Holland

Summary: HLA typing was performed on 336 Maasai participants using locus-specific amplicon sequencing at the HLA-A,-B,-C,-DRB1,-DQB1 and-DPB1 loci. The participants were recruited from three villages in North Tanzania for a study on risk factors for trachomatous scarring in children. Apart from the HLA-A locus, all other loci significantly deviated from Hardy-Weinberg equilibrium, possibly due to high relatedness among individuals: 238 individuals shared a household with at least one other participant. The most frequent alleles at each locus were A*68:02 (14.3%), B*53:01 (8.4%), C*06:02 (19.2%), DRB1*13:02 (17.7%), DQB1*02:01 (16.9%), and DPB1*01:01 (15.7%), while the most common inferred haplotype was A*68:02 B*18:01 C*07:04 DRB1*08:04 DQB1*04:02 DPB1*04:01 (1.3%).

HUMAN IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Alexander J. Mentzer, Daniel O'Connor, Sagida Bibi, Irina L. Chelysheva, Elizabeth A. Clutterbuck, Tesfaye Demissie, Tanya Dinesh, Nick M. Edwards, Sally Felle, Shuo C. Feng, Amy Flaxman, Eleanor Karp-Tatham, Grace Li, Xinxue J. Liu, Natalie Marchevsky, Leila Godfrey, Rebecca K. Makinson, Maireid O. Bull, Jamie N. Fowler, Bana Alamad, Tomas Malinauskas, Amanda Chong, Katherine Sanders, Robert Shaw, Merryn Voysey, Matthew D. Snape, Andrew J. Pollard, Teresa Lambe, Julian C. Knight

Summary: Variation in antibody levels elicited by the COVID-19 vaccine ChAdOx1 nCov-19 is linked to specific major histocompatibility complex class II alleles, providing insight into the breadth of immune response among vaccinated individuals. HLA-DQB1*06 allele is associated with higher levels of anti-RBD antibody and decreased risk of breakthrough infection. These findings have implications for future vaccine design and implementation.

NATURE MEDICINE (2023)

Article Infectious Diseases

The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort

Stephanie Rimmer, James Barnacle, Malick M. Gibani, Oshani Dissanayake, Ravi Mehta, Trent Herdman, Mark Gilchrist, David Muir, Umar Ebrahimsa, Borja Mora-Peris, Olamide Dosekun, Lucy Garvey, Joanna Peters, Frances Davies, Graham Cooke, Aula Abbara

Summary: Since May 2022, cases of human monkeypox virus (hMPXV) with human-to-human cross-transmission have increased in nonendemic countries. The study aimed to characterize diagnostic features of patients with confirmed and possible monkeypox and to describe a virtual care model.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Bacterial shedding and serologic responses following an outbreak of Salmonella Typhi in an endemic cohort

Peter I. Johnston, Patrick Bogue, Angeziwa Chunga Chirambo, Maurice Mbewe, Reenesh Prakash, Vanessa Kandoole-Kabwere, Rebecca Lester, Thomas Darton, Stephen Baker, Melita A. Gordon, James E. Meiring

Summary: This study aimed to identify patients who were shedding Salmonella Typhi in stool following a typhoid outbreak by serosurveillance. A typhoid outbreak in a nursing school in Malawi was investigated, and serum samples and stool samples were collected for bacterial culture and PCR testing. The study found that high titres of anti-Vi antibodies did not effectively detect Salmonella Typhi shedding. Additionally, non-typhoidal salmonellae were found in drinking water, indicating poor sanitation.

BMC INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study-A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

Robert H. Shaw, Melanie Greenland, Arabella S. V. Stuart, Parvinder K. Aley, Nick J. Andrews, J. Claire Cameron, Sue Charlton, Elizabeth A. Clutterbuck, Andrea M. Collins, Tom Darton, Tanya Dinesh, Christopher J. A. Duncan, Saul N. Faust, Daniela M. Ferreira, Adam Finn, Anna L. Goodman, Christopher A. Green, Bassam Hallis, Paul T. Heath, Helen Hill, Teresa Lambe, Vincenzo Libri, Patrick J. Lillie, Ella Morey, Yama F. Mujadidi, Ruth Payne, Emma L. Plested, Samuel Provstgaard-Morys, Maheshi N. Ramasamy, Mary Ramsay, Robert C. Read, Hannah Robinson, Gavin R. Screaton, Nisha Singh, David P. J. Turner, Paul J. Turner, Rachel White, Jonathan S. Nguyen-Van-Tam, Xinxue Liu, Matthew D. Snape

Summary: This report aims to understand the persistence of immune response to different COVID-19 vaccine platforms used in homologous and heterologous priming combinations, which will inform future vaccine development.

JOURNAL OF INFECTION (2023)

Article Medicine, General & Internal

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby, Jonathan R. Emberson, Buddha Basnyat, Mark Campbell, Leon Peto, Guilherme Pessoa-Amorim, Natalie Staplin, Raph L. Hamers, John Amuasi, Jeremy Nel, Evelyne Kestelyn, Manisha Rawal, Roshan Kumar Jha, Nguyen Thanh Phong, Uun Sumardi, Damodar Paudel, Pham Ngoc Thach, Nasronudin Nasronudin, Emma Stratton, Louise Mew, Rahuldeb Sarkar, J. Kenneth Baillie, Maya H. Buch, Jeremy Day, Saul N. Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Marion Mafham, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Richard Haynes, Martin J. Landray

Summary: This study evaluated the use of high-dose corticosteroids in COVID-19 patients. The results showed that in hospitalized patients with COVID-19, high-dose corticosteroids increased the risk of death compared to low-dose corticosteroids.

LANCET (2023)

Article Infectious Diseases

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

Ivan Lee, Catherine A. Cosgrove, Patrick Moore, Claire Bethune, Rhiannon Nally, Marcin Bula, Philip A. Kalra, Rebecca Clark, Paul Dargan, Marta Boffito, Ray Sheridan, Ed Moran, Thomas C. Darton, Fiona Burns, Dinesh Saralaya, Christopher J. A. Duncan, Patrick J. Lillie, Alberto San Francisco Ramos, Eva P. Galiza, Paul Heath, Bethany Girard, Christy Parker, Dondi Rust, Shraddha Mehta, Elizabeth de Windt, Andrea Sutherland, Joanne E. Tomassini, Frank J. Dutko, Spyros Chalkias, Weiping Deng, Xing Chen, Jing Feng, Laree Tracy, Honghong Zhou, Jacqueline M. Miller, Rituparna Das

Summary: The results of this large randomized controlled trial showed that the Omicron BA.1 monovalent and bivalent boosters have superior immunogenicity against the Omicron BA.1 variant compared to the original vaccine, while having comparable immunogenicity against the original strain. Both boosters had similar safety profiles to the original vaccine.

LANCET INFECTIOUS DISEASES (2023)

Article Immunology

Early transcriptional responses to human enteric fever challenge

Amber Barton, Jennifer Hill, Daniel O'Connor, Claire Jones, Elizabeth Jones, Susana Camara, Sonu Shrestha, Celina Jin, Malick M. Gibani, Hazel C. Dobinson, Claire Waddington, Thomas C. Darton, Christoph J. Blohmke, Andrew J. Pollard

Summary: Enteric fever, caused by oral infection with typhoidal Salmonella serovars, presents as a non-specific febrile illness preceded by an incubation period of 5 days or more. The enteric fever human challenge model provides a unique opportunity to investigate the innate immune response during this incubation period, and how this response is altered by vaccination with the Vi polysaccharide or conjugate vaccine. We find that on the same day as ingestion of typhoidal Salmonella, there is already evidence of an immune response, with 199 genes upregulated in the peripheral blood transcriptome 12 hours post-challenge (false discovery rate <0.05). Gene sets relating to neutrophils, monocytes, and innate immunity were over-represented (false discovery rate <0.05). Estimating cell proportions from gene expression data suggested a possible increase in activated monocytes 12 hours post-challenge (P = 0.036, paired Wilcoxon signed-rank test). Furthermore, plasma TNF-α rose following exposure (P = 0.011, paired Wilcoxon signed-rank test). There were no significant differences in gene expression (false discovery rate <0.05) in the 12 hours response between those who did and did not subsequently develop clinical or blood culture confirmed enteric fever or between vaccination groups. Together, these results demonstrate early perturbation of the peripheral blood transcriptome after enteric fever challenge and provide initial insight into early mechanisms of protection.

INFECTION AND IMMUNITY (2023)

Review Immunology

The immune evasion roles of Staphylococcus aureus protein A and impact on vaccine development

Alex Bear, Thomas Locke, Sarah Rowland-Jones, Simone Pecetta, Fabio Bagnoli, Thomas C. Darton

Summary: This article discusses the mechanisms of S. aureus infection and the importance of immune evasion, with a focus on the protein SpA. Understanding the mechanisms of immune evasion is crucial for the development of effective vaccines and monoclonal antibodies.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

Article Endocrinology & Metabolism

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby, Natalie Staplin, Leon Peto, Jonathan R. Emberson, Mark Campbell, Guilherme Pessoa-Amorim, Buddha Basnyat, Louise Thwaites, Rogier van Doorn, Raph L. Hamers, Jeremy Nel, John Amuasi, Manisha Rawal, Dipansu Ghosh, Jonathan Douse, Fergus Hamilton, Anthony Kerry, Pinky Thu-Ta, John Widdrington, Christopher A. Green, Purav Desai, Richard Stewart, Nguyen Thanh Phong, J. Kenneth Baillie, Maya Buch, Saul N. Faust, Thomas Jaki, Edmund Juszczak, Katie Jeffery, Marian Knight, Wei Shen Lim, Alan Montgomery, Aparna Mukherjee, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J. Landray

Summary: Empagliflozin is not associated with reduced mortality, hospital stay, or progression to invasive mechanical ventilation or death in hospitalized adults with COVID-19.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Biology

Direct inference and control of genetic population structure from RNA sequencing data

Muhamad Fachrul, Abhilasha M. Karkey, Mila Shakya, Louise Judd, Taylor Harshegyi, Kar Seng Sim, Susan Tonks, Sabina Dongol, Rajendra Shrestha, Agus Salim, Happy Chimphako STRATAA Study Grp, Anup Adhikari, Happy Chimphako C. Banda, Christoph Blohmke, Thomas Darton, Yama Farooq, Maheshwar Ghimire, Jennifer Hill, Nhu Tran Hoang, Tikhala Makhaza Jere, Moses Kamzati, Yu-Han Kao, Clemens Masesa, Maurice Mbewe, Harrison Msuku, Patrick Munthali, Tran Vu Thieu J. Nga, Rose Nkhata, Neil Saad, Trinh Van Tan, Deus Thindwa, Farhana D. Khanam, James Meiring, John E. Clemens, Gordon Dougan, Virginia S. Pitzer, Firdausi A. Qadri, Robert Heyderman, Melita Gordon, Merryn J. Voysey, Stephen Baker, Andrew Pollard, Chiea Chuen Khor, Christiane J. Dolecek, Buddha E. Basnyat, Sarah Dunstan, Kathryn Holt, Michael Inouye

Summary: Researchers developed a computational tool called RGStraP to estimate genetic principal components (RG-PCs) using RNAseq data and examined its use in controlling for population structure in gene expression analyses. They found that RG-PCs had similar results to paired array-based genotypes and could effectively capture subpopulations within the dataset. The inclusion of RG-PCs as covariates in differential gene expression analysis reduced test statistic inflation.

COMMUNICATIONS BIOLOGY (2023)

Article Infectious Diseases

Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

Ioannis Baltas, Mark Gilchrist, Eirini Koutoumanou, Malick M. Gibani, James E. Meiring, Akaninyene Otu, David Hettle, Ameeka Thompson, James R. Price, Anna Crepet, Abolaji Atomode, Timothy Crocker-Buque, Dimitrios Spinos, Hudson Guyver, Matija Tausan, Donald Somasunderam, Maxwell Thoburn, Cathleen Chan, Helen Umpleby, Bethany Sharp, Callum Chivers, Devan Suresh Vaghela, Ronak J. Shah, Jonathan Foster, Amy Hume, Christopher Smith, Ammara Asif, Dimitrios Mermerelis, Mohammad Abbas Reza, Dominic A. Haigh, Thomas Lamb, Loucia Karatzia, Alexandra Bramley, Nikhil Kadam, Konstantinos Kavallieros, Veronica Garcia-Arias, Jane Democratis, Claire S. Waddington, Luke S. P. Moore, Alexander M. Aiken

Summary: A new 'subscription-type' funding model for ceftazidime/avibactam and cefiderocol was launched in England. A survey was conducted to explore the views of infection consultants on this delinked antimicrobial funding model. The majority of consultants welcomed the model, believing it will improve treatment of drug-resistant infections and stimulate research and development of new antimicrobials. However, there were disagreements regarding the model's impact on carbapenem use.

JAC-ANTIMICROBIAL RESISTANCE (2023)

Meeting Abstract Infectious Diseases

Urinary tract infections in HSCT: how big is the problem?

Ioannis Baltas, Konstantinos Kavallieros, Ioannis Konstantinou, Malick M. Gibani, Frances Davies, Jiri Pavlu

JAC-ANTIMICROBIAL RESISTANCE (2023)

Article Medicine, Research & Experimental

Molecular correlates of vaccine-induced protection against typhoid fever

Henderson Zhu, Irina Chelysheva, Deborah L. Cross, Luke Blackwell, Celina Jin, Malick M. Gibani, Elizabeth Jones, Jennifer Hill, Johannes Truck, Dominic F. Kelly, Christoph J. Blohmke, Andrew J. Pollard, Daniel O'Connor

Summary: This study compares the immune responses and protection effects of two typhoid vaccines, ViPS and ViTT, through the analysis of genomic data. The study reveals distinct molecular features between the two vaccines, mainly related to humoral immune responses. Furthermore, the study identifies molecular correlates of protection against S. Typhi infection. These findings have important implications for future vaccine design and assessment.

JOURNAL OF CLINICAL INVESTIGATION (2023)

No Data Available